Appleby Bermuda advised Sumitomo Dainippon Pharma Co., Ltd., a leading TSE listed (TYO:4506) Japanese pharmaceutical company in respect of its estimated  USD 3 billion acquisition of 5 biopharma companies via the transfer by Roivant Sciences Ltd. of its ownership interests in Myovant Sciences Ltd., Urovant Sciences Ltd., Enzyvant Therapeutics Ltd., Altavant Sciences Ltd., and Spirovant Sciences Ltd to Sumitovant Biopharma Ltd., a wholly owned subsidiary of Sumitomo.

Partner Brad Adderley led the deal with assistance from Partner Gary Harris and Associate Jamie Rego. Brad said, “We are pleased to have acted as Bermuda counsel to Sumitomo Dainippon Pharma on this significant acquisition and wish them continued success.”

Share
Twitter LinkedIn Email Save as PDF
More Deals
17 Mar 2023 | Deals

Appleby Bermuda advised Swiss Re on its USD 700 million multi-year stop-loss transaction

Appleby acted as Bermuda counsel for global reinsurer Swiss Re on its securing a multi-year stop-los...

24 Jan 2023 | Deals

Appleby advises Wejo Group Limited on its entry into a business combination with TKB Critical Technologies I

Appleby is acting as Bermuda and Cayman Islands counsel to Nasdaq-listed Wejo Group Limited, a globa...

16 Jan 2023 | Deals

Appleby Bermuda advised on Kuvare Holdings Launch of USD 400 Million Kindley Re Sidecar

Appleby advised Kuvare Holdings (Kuvare) on its formation of Kindley Re Ltd. (Kindley Re), a newly f...

8 Dec 2022 | Deals

Appleby Bermuda advised African Risk Capacity Ltd on its first epidemic risk insurance product

Appleby Bermuda advised ARC Ltd, a long-standing client, on its first parametric insurance product a...

26 Sep 2022 | Deals

Appleby Supports Northedge Investment into Friend MTS, a Leading Global Provider of Video Content Security Services

Appleby is proud to have acted as Jersey and Bermuda counsel, alongside Gateley PLC, to private equ...

23 Aug 2022 | Deals

Appleby Bermuda advised CoinZoom on its Digital Asset Business licence

Appleby advised CoinZoom, Inc. on its application for a Class M Digital Asset Business licence pursu...

11 May 2022 | Deals

Appleby Bermuda Advised Relm II In Its Incorporation And Registration To Provide Reinsurance Capacity In The Crypto Space

Appleby served as Bermuda counsel to Relm Insurance II Ltd. (Relm II) in connection with its incorpo...

5 May 2022 | Deals

SkyRidge Re team wins ‘Life Transaction of the Year’ at the Trading Risk Awards 2022

Congratulations to the SkyRidge Re team for winning ‘Life Transaction of the Year’ at the Tradin...

19 Apr 2022 | Deals

Appleby Bermuda Advised Swiss Re In Innovative USD1.15bn Transaction Combining Bank Financing And Insurance-Linked Securities

Appleby acted as Bermuda counsel to Swiss Re, a leading wholesale provider of reinsurance, insurance...

4 Mar 2022 | Deals

Appleby Bermuda advised S&P Global in its USD 140 billion merger with IHS Markit

Appleby acted as Bermuda counsel to S&P Global, the world's foremost provider of credit ratings,...